Physician profile
Amanda Warner
NPI 1033676275
$729.88
in general payments reported to CMS, 2019-2025
17 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.21 · 2022: $88.21 · 2023: $55.04 · 2024: $265 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $126.37 | 2024-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $67.44 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $62.75 | 2021-2022 | |
| Medtronic, INC. | $58.79 | 2024-2025 | Inpen Smart Insulin Delivery System |
| Dexcom, INC. | $48.25 | 2024 | Dexcom G6 Transmitter |
| Beta Bionics, INC. | $46.79 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Xeris Pharmaceuticals, INC. | $45.16 | 2025 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.03 | 2022-2024 | Jardiance |
| Ascensia Diabetes Care US INC. | $35.20 | 2024 | |
| Insulet Corporation | $34.79 | 2022-2024 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $32.85 | 2024-2025 | |
| Lilly USA, LLC | $28.07 | 2022 | |
| Mannkind Corporation | $23.87 | 2023 | Afrezza |
| Cequr Corporation | $22.86 | 2025 | Cequr Simplicity |
| Glaxosmithkline, LLC. | $19.50 | 2025 | Arexvy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequel Med Tech, LLC | $17.66 | 2025 | Twiist |
| Lexicon Pharmaceuticals, INC. | $17.50 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.